Leader R.E. moves into Russia

The Leader Real Estate Group International, a division of Tel Aviv-based Leader Holdings, announced on Sunday that it has purchased building rights for a project it will construct about 70 kilometers from Moscow.

By MATTHEW KRIEGER
September 10, 2007 07:51

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The Leader Real Estate Group International, a division of Tel Aviv-based Leader Holdings, announced on Sunday that it has purchased building rights for a project it will construct about 70 kilometers from Moscow. The project, which will include 7,000 residential units covering some 345,000 square meters, plus a 13,000 square meter business center and 8,000 square meters of public office space, is expected to generate $375m. in sales for the company. This is the first Russian project for Leader.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS